Search hospitals > Kentucky > Madisonville
Baptist Health Madisonville/Merle Mahr Cancer Center
Claim this profileMadisonville, Kentucky 42431
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Brain Tumor
97 reported clinical trials
7 medical researchers
Summary
Baptist Health Madisonville/Merle Mahr Cancer Center is a medical facility located in Madisonville, Kentucky. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Brain Tumor and other specialties. Baptist Health Madisonville/Merle Mahr Cancer Center is involved with conducting 97 clinical trials across 153 conditions. There are 7 research doctors associated with this hospital, such as Firas Badin, MD, Lee Hicks, Hope Cottrill, and Monica Vetter, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage II
Stage I
Stage III
Top PIs
Firas Badin, MDBaptist Health Lexington4 years of reported clinical research
Expert in Non-Small Cell Lung Cancer
Studies Lung Cancer
12 reported clinical trials
23 drugs studied
Lee HicksBaptist Health Lexington6 years of reported clinical research
Studies Colorectal Cancer
Studies Colon Cancer
8 reported clinical trials
22 drugs studied
Hope CottrillBaptist Health Lexington1 year of reported clinical research
Studies Ovarian Cancer
Studies Fallopian Tube Cancer
9 reported clinical trials
23 drugs studied
Monica Vetter, MDBaptist Health Lexington1 year of reported clinical research
Studies Ovarian Cancer
Studies Serous Cystadenocarcinoma
6 reported clinical trials
14 drugs studied
Clinical Trials running at Baptist Health Madisonville/Merle Mahr Cancer Center
Non-Small Cell Lung Cancer
Lung Cancer
Breast Cancer
Ovarian Cancer
Fallopian Tube Cancer
Pancreatic Cancer
Peritoneal Cancer
Cancer
ALK Gene Rearrangement
Squamous Cell Carcinoma
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Baptist Health Madisonville/Merle Mahr Cancer Center?
Baptist Health Madisonville/Merle Mahr Cancer Center is a medical facility located in Madisonville, Kentucky. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Brain Tumor and other specialties. Baptist Health Madisonville/Merle Mahr Cancer Center is involved with conducting 97 clinical trials across 153 conditions. There are 7 research doctors associated with this hospital, such as Firas Badin, MD, Lee Hicks, Hope Cottrill, and Monica Vetter, MD.